365 Randomized trial between selective aromatase inhibitor formestane (®lentaron) vs tamoxifen as first-line hormonal therapy in postmenopausal patients with advanced breast cancer: Confirmation of bioequivalence in survival

✍ Scribed by L. Mauriac; R. Pérez Carrion; V. Alberola; F. Calabresi; R.Th. Michel; R. Santos; E. Wehrle; C.M. Royce

• Book ID: 116167120
• Publisher: Elsevier Science
• Year: 1995
• Tongue: English
• Weight: 153 KB
• Volume: 31
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/0959-8049(95)95618-g